☰

Rafael Franco - Publications

Affiliations: 
Universitat de Barcelona, Barcelona, Cataluña, Spain 
Area:
Membrane Receptors and Intercellular Communication
Website:
https://www.bq.ub.edu/recep/franco.html
Tree Info Similar researchers PubMed Report error

74 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Navarro G, Gonzalez A, Campanacci S, Rivas-Santisteban R, Reyes-Resina I, Casajuana-Martin N, Cordomí A, Pardo L, Franco R. Experimental and computational analysis of biased agonism on full-length and a C-terminally truncated adenosine A receptor. Computational and Structural Biotechnology Journal. 18: 2723-2732. PMID 33101610 DOI: 10.1016/j.csbj.2020.09.028  0.315
2019 De Filippo E, Hinz S, Pellizzari V, Deganutti G, El-Tayeb A, Navarro G, Franco R, Moro S, Schiedel AC, Müller CE. A and A adenosine receptors: the extracellular loop 2 determines high (A) or low affinity (A) for adenosine. Biochemical Pharmacology. 113718. PMID 31751537 DOI: 10.1016/J.Bcp.2019.113718  0.318
2018 Franco R, Aguinaga D, Jiménez J, Lillo J, Martínez-Pinilla E, Navarro G. Biased receptor functionality versus biased agonism in G-protein-coupled receptors. Biomolecular Concepts. 9: 143-154. PMID 30864350 DOI: 10.1515/bmc-2018-0013  0.313
2018 Navarro G, Medrano M, Aguinaga D, Vega-Quiroga I, Lillo A, Jiménez J, Casanovas M, Canela EI, Mallol J, Gysling K, Franco R. Differential effect of amphetamine over the corticotropin-releasing factor CRF receptor, the orexin OX receptor and the CRF-OX heteroreceptor complex. Neuropharmacology. PMID 30465812 DOI: 10.1016/j.neuropharm.2018.11.014  0.353
2018 Reyes-Resina I, Navarro G, Aguinaga D, Canela EI, Schoeder CT, Zaluski M, Kiec-Kononowicz K, Saura CA, Müller CE, Franco R. Molecular and functional interaction between GPR18 and cannabinoid CB G-protein-coupled receptors. Relevance in neurodegenerative diseases. Biochemical Pharmacology. PMID 29870711 DOI: 10.1016/J.Bcp.2018.06.001  0.344
2018 Hinz S, Navarro G, Borroto-Escuela D, Seibt BF, Ammon YC, de Filippo E, Danish A, Lacher SK, Červinková B, Rafehi M, Fuxe K, Schiedel AC, Franco R, Müller CE. Adenosine Areceptor ligand recognition and signaling is blocked by Areceptors. Oncotarget. 9: 13593-13611. PMID 29568380 DOI: 10.18632/Oncotarget.24423  0.316
2018 Navarro G, Cordomí A, Brugarolas M, Moreno E, Aguinaga D, Pérez-Benito L, Ferre S, Cortés A, Casadó V, Mallol J, Canela EI, Lluís C, Pardo L, McCormick PJ, Franco R. Cross-communication between Gand Gin a G-protein-coupled receptor heterotetramer guided by a receptor C-terminal domain. Bmc Biology. 16: 24. PMID 29486745 DOI: 10.1186/S12915-018-0491-X  0.307
2018 Reyes-Resina I, Aguinaga D, Labandeira-García JL, Lanciego JL, Navarro G, Franco R. Usefulness of identifying G-protein-coupled receptor dimers for diagnosis and therapy of neurodegenerative diseases and of gliomas. Histology and Histopathology. 11963. PMID 29336473 DOI: 10.14670/HH-11-963  0.316
2016 Rodríguez-Ruiz M, Moreno E, Moreno-Delgado D, Navarro G, Mallol J, Cortés A, Lluís C, Canela EI, Casadó V, McCormick PJ, Franco R. Heteroreceptor Complexes Formed by Dopamine D1, Histamine H3, and N-Methyl-D-Aspartate Glutamate Receptors as Targets to Prevent Neuronal Death in Alzheimer's Disease. Molecular Neurobiology. PMID 27370794 DOI: 10.1007/S12035-016-9995-Y  0.315
2016 Martinez-Pinilla E, Rabal O, Reyes-Resina I, Zamarbide M, Navarro G, Sanchez-Arias JA, de Miguel I, Lanciego JL, Oyarzabal J, Franco R. Two affinity sites of cannabinoid CB2 receptor identified by a novel homogeneous binding assay. The Journal of Pharmacology and Experimental Therapeutics. PMID 27358483 DOI: 10.1124/Jpet.116.234948  0.327
2016 Franco R, Martínez-Pinilla E, Lanciego JL, Navarro G. Basic Pharmacological and Structural Evidence for Class A G-Protein-Coupled Receptor Heteromerization. Frontiers in Pharmacology. 7: 76. PMID 27065866 DOI: 10.3389/fphar.2016.00076  0.325
2014 George SR, Kern A, Smith RG, Franco R. Dopamine receptor heteromeric complexes and their emerging functions. Progress in Brain Research. 211: 183-200. PMID 24968781 DOI: 10.1016/B978-0-444-63425-2.00008-8  0.303
2014 Pinna A, Bonaventura J, Farré D, Sánchez M, Simola N, Mallol J, Lluís C, Costa G, Baqi Y, Müller CE, Cortés A, McCormick P, Canela EI, Martínez-Pinilla E, Lanciego JL, ... ... Franco R, et al. L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies. Experimental Neurology. 253: 180-91. PMID 24412491 DOI: 10.1016/J.Expneurol.2013.12.021  0.305
2013 Navarro G, McCormick PJ, Mallol J, Lluís C, Franco R, Cortés A, Casadó V, Canela EI, Ferré S. Detection of receptor heteromers involving dopamine receptors by the sequential BRET-FRET technology. Methods in Molecular Biology (Clifton, N.J.). 964: 95-105. PMID 23296780 DOI: 10.1007/978-1-62703-251-3_7  0.342
2013 Gracia E, Farré D, Cortés A, Ferrer-Costa C, Orozco M, Mallol J, Lluís C, Canela EI, McCormick PJ, Franco R, Fanelli F, Casadó V. The catalytic site structural gate of adenosine deaminase allosterically modulates ligand binding to adenosine receptors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 1048-61. PMID 23193172 DOI: 10.1096/Fj.12-212621  0.422
2012 Canela L, Selga E, García-Martínez JM, Amaral OB, Fernández-Dueñas V, Alberch J, Canela EI, Franco R, Noé V, Lluís C, Ciudad CJ, Ciruela F. Transcriptional profiling of striatal neurons in response to single or concurrent activation of dopamine D2, adenosine A(2A) and metabotropic glutamate type 5 receptors: focus on beta-synuclein expression. Gene. 508: 199-205. PMID 22892378 DOI: 10.1016/J.Gene.2012.07.074  0.32
2012 Callén L, Moreno E, Barroso-Chinea P, Moreno-Delgado D, Cortés A, Mallol J, Casadó V, Lanciego JL, Franco R, Lluis C, Canela EI, McCormick PJ. Cannabinoid receptors CB1 and CB2 form functional heteromers in brain. The Journal of Biological Chemistry. 287: 20851-65. PMID 22532560 DOI: 10.1074/Jbc.M111.335273  0.356
2011 Aymerich MS, López-Azcárate J, Bonaventura J, Navarro G, Fernández-Suárez D, Casadó V, Mayor F, Lluís C, Valencia M, Artieda J, Franco R. Real-Time G-Protein-Coupled Receptor Imaging to Understand and Quantify Receptor Dynamics The Scientific World Journal. 11: 1995-2010. PMID 22125451 DOI: 10.1100/2011/690858  0.317
2011 Armentero MT, Pinna A, Ferré S, Lanciego JL, Müller CE, Franco R. Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease Pharmacology & Therapeutics. 132: 280-299. PMID 21810444 DOI: 10.1016/J.Pharmthera.2011.07.004  0.339
2011 Moreno E, Vaz SH, Cai NS, Ferrada C, Quiroz C, Barodia SK, Kabbani N, Canela EI, McCormick PJ, Lluis C, Franco R, Ribeiro JA, Sebastião AM, Ferré S. Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 7412-23. PMID 21593325 DOI: 10.1523/Jneurosci.0191-11.2011  0.339
2011 Gracia E, Pérez-Capote K, Moreno E, Barkešová J, Mallol J, Lluís C, Franco R, Cortés A, Casadó V, Canela EI. A2A adenosine receptor ligand binding and signalling is allosterically modulated by adenosine deaminase. The Biochemical Journal. 435: 701-9. PMID 21306300 DOI: 10.1042/BJ20101749  0.334
2011 Moreno E, Hoffmann H, Gonzalez-Sepúlveda M, Navarro G, Casadó V, Cortés A, Mallol J, Vignes M, McCormick PJ, Canela EI, Lluís C, Moratalla R, Ferré S, Ortiz J, Franco R. Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. The Journal of Biological Chemistry. 286: 5846-54. PMID 21173143 DOI: 10.1074/Jbc.M110.161489  0.321
2011 Ferré S, Lluis C, Lanciego JL, Franco R. Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D₁-D₃ receptor heteromer. Cns & Neurological Disorders Drug Targets. 9: 596-600. PMID 20632968 DOI: 10.2174/187152710793361603  0.336
2010 Ferré S, Lluís C, Justinova Z, Quiroz C, Orru M, Navarro G, Canela EI, Franco R, Goldberg SR. Adenosine-cannabinoid receptor interactions. Implications for striatal function. British Journal of Pharmacology. 160: 443-53. PMID 20590556 DOI: 10.1111/j.1476-5381.2010.00723.x  0.321
2010 Navarro G, Ferré S, Cordomi A, Moreno E, Mallol J, Casadó V, Cortés A, Hoffmann H, Ortiz J, Canela EI, Lluís C, Pardo L, Franco R, Woods AS. Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers. The Journal of Biological Chemistry. 285: 27346-59. PMID 20562103 DOI: 10.1074/Jbc.M110.115634  0.36
2010 Ferré S, Woods AS, Navarro G, Aymerich M, Lluís C, Franco R. Calcium-mediated modulation of the quaternary structure and function of adenosine A2A-dopamine D2 receptor heteromers. Current Opinion in Pharmacology. 10: 67-72. PMID 19896897 DOI: 10.1016/J.Coph.2009.10.002  0.34
2009 Martínez Muñoz L, Lucas P, Navarro G, Checa AI, Franco R, Martínez-A C, Rodríguez-Frade JM, Mellado M. Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers. Journal of Immunology (Baltimore, Md. : 1950). 183: 7337-46. PMID 19890050 DOI: 10.4049/jimmunol.0901802  0.331
2009 Canela L, Fernández-Dueñas V, Albergaria C, Watanabe M, Lluís C, Mallol J, Canela EI, Franco R, Luján R, Ciruela F. The association of metabotropic glutamate receptor type 5 with the neuronal Ca2+-binding protein 2 modulates receptor function. Journal of Neurochemistry. 111: 555-67. PMID 19694902 DOI: 10.1111/J.1471-4159.2009.06348.X  0.347
2009 Navarro G, Aymerich MS, Marcellino D, Cortés A, Casadó V, Mallol J, Canela EI, Agnati L, Woods AS, Fuxe K, Lluís C, Lanciego JL, Ferré S, Franco R. Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. The Journal of Biological Chemistry. 284: 28058-68. PMID 19632986 DOI: 10.1074/Jbc.M109.034231  0.339
2009 Ferrada C, Moreno E, Casadó V, Bongers G, Cortés A, Mallol J, Canela EI, Leurs R, Ferré S, Lluís C, Franco R. Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors. British Journal of Pharmacology. 157: 64-75. PMID 19413572 DOI: 10.1111/J.1476-5381.2009.00152.X  0.333
2009 Cabello N, Gandía J, Bertarelli DC, Watanabe M, Lluís C, Franco R, Ferré S, Luján R, Ciruela F. Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells. Journal of Neurochemistry. 109: 1497-507. PMID 19344374 DOI: 10.1111/J.1471-4159.2009.06078.X  0.346
2009 Ferré S, Goldberg SR, Lluis C, Franco R. Looking for the role of cannabinoid receptor heteromers in striatal function. Neuropharmacology. 56: 226-34. PMID 18691604 DOI: 10.1016/j.neuropharm.2008.06.076  0.318
2008 Navarro G, Carriba P, Gandía J, Ciruela F, Casadó V, Cortés A, Mallol J, Canela EI, Lluis C, Franco R. Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer. Thescientificworldjournal. 8: 1088-97. PMID 18956124 DOI: 10.1100/Tsw.2008.136  0.303
2008 Gracia E, Cortés A, Meana JJ, García-Sevilla J, Herhsfield MS, Canela EI, Mallol J, Lluís C, Franco R, Casadó V. Human adenosine deaminase as an allosteric modulator of human A1 adenosine receptor: abolishment of negative cooperativity for [3H](R)‐pia binding to the caudate nucleus Journal of Neurochemistry. 107: 161-170. PMID 18680557 DOI: 10.1111/J.1471-4159.2008.05602.X  0.331
2008 Gandia J, Galino J, Amaral OB, Soriano A, Lluís C, Franco R, Ciruela F. Detection of higher-order G protein-coupled receptor oligomers by a combined BRET-BiFC technique. Febs Letters. 582: 2979-84. PMID 18675812 DOI: 10.1016/J.Febslet.2008.07.045  0.313
2008 Franco R, Casadó V, Cortés A, Pérez-Capote K, Mallol J, Canela E, Ferré S, Lluis C. Novel pharmacological targets based on receptor heteromers. Brain Research Reviews. 58: 475-82. PMID 18620000 DOI: 10.1016/j.brainresrev.2008.06.002  0.351
2008 Woods AS, Marcellino D, Jackson SN, Franco R, Ferré S, Agnati LF, Fuxe K. How calmodulin interacts with the adenosine A(2A) and the dopamine D(2) receptors. Journal of Proteome Research. 7: 3428-34. PMID 18590318 DOI: 10.1021/Pr8001782  0.353
2008 Ferrada C, Ferré S, Casadó V, Cortés A, Justinova Z, Barnes C, Canela EI, Goldberg SR, Leurs R, Lluis C, Franco R. Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology. 55: 190-7. PMID 18547596 DOI: 10.1016/J.Neuropharm.2008.05.008  0.33
2008 Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology. 54: 815-23. PMID 18262573 DOI: 10.1016/J.Neuropharm.2007.12.011  0.36
2008 Ferre S, Ciruela F, Borycz J, Solinas M, Quarta D, Antoniou K, Quiroz C, Justinova Z, Lluis C, Franco R, Goldberg SR. Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain. Frontiers in Bioscience : a Journal and Virtual Library. 13: 2391-9. PMID 17981720 DOI: 10.2741/2852  0.333
2007 Ferré S, Ciruela F, Quiroz C, Luján R, Popoli P, Cunha RA, Agnati LF, Fuxe K, Woods AS, Lluis C, Franco R. Adenosine receptor heteromers and their integrative role in striatal function. Thescientificworldjournal. 7: 74-85. PMID 17982579 DOI: 10.1100/Tsw.2007.211  0.369
2007 Franco R, Casadó V, Cortés A, Ferrada C, Mallol J, Woods A, Lluis C, Canela EI, Ferré S. Basic concepts in G-protein-coupled receptor homo- and heterodimerization. Thescientificworldjournal. 7: 48-57. PMID 17982576 DOI: 10.1100/Tsw.2007.197  0.349
2007 Casadó V, Cortés A, Ciruela F, Mallol J, Ferré S, Lluis C, Canela EI, Franco R. Old and new ways to calculate the affinity of agonists and antagonists interacting with G-protein-coupled monomeric and dimeric receptors: the receptor-dimer cooperativity index. Pharmacology & Therapeutics. 116: 343-54. PMID 17935788 DOI: 10.1016/J.Pharmthera.2007.05.010  0.343
2007 Fredholm BB, Chern Y, Franco R, Sitkovsky M. Aspects of the general biology of adenosine A2A signaling. Progress in Neurobiology. 83: 263-76. PMID 17804147 DOI: 10.1016/J.Pneurobio.2007.07.005  0.35
2007 Ferré S, Ciruela F, Woods AS, Lluis C, Franco R. Functional relevance of neurotransmitter receptor heteromers in the central nervous system. Trends in Neurosciences. 30: 440-6. PMID 17692396 DOI: 10.1016/J.Tins.2007.07.001  0.341
2007 Canela L, Luján R, Lluís C, Burgueño J, Mallol J, Canela EI, Franco R, Ciruela F. The neuronal Ca(2+) -binding protein 2 (NECAB2) interacts with the adenosine A(2A) receptor and modulates the cell surface expression and function of the receptor. Molecular and Cellular Neurosciences. 36: 1-12. PMID 17689978 DOI: 10.1016/J.Mcn.2007.05.007  0.322
2007 Fuxe K, Ferré S, Genedani S, Franco R, Agnati LF. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiology & Behavior. 92: 210-7. PMID 17572452 DOI: 10.1016/j.physbeh.2007.05.034  0.361
2007 Ferré S, Agnati LF, Ciruela F, Lluis C, Woods AS, Fuxe K, Franco R. Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module. Brain Research Reviews. 55: 55-67. PMID 17408563 DOI: 10.1016/J.Brainresrev.2007.01.007  0.353
2007 Carriba P, Ortiz O, Patkar K, Justinova Z, Stroik J, Themann A, Müller C, Woods AS, Hope BT, Ciruela F, Casadó V, Canela EI, Lluis C, Goldberg SR, Moratalla R, ... Franco R, et al. Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2249-59. PMID 17356572 DOI: 10.1038/Sj.Npp.1301375  0.325
2007 Cabello N, Remelli R, Canela L, Soriguera A, Mallol J, Canela EI, Robbins MJ, Lluis C, Franco R, McIlhinney RA, Ciruela F. Actin-binding protein alpha-actinin-1 interacts with the metabotropic glutamate receptor type 5b and modulates the cell surface expression and function of the receptor. The Journal of Biological Chemistry. 282: 12143-53. PMID 17311919 DOI: 10.1074/Jbc.M608880200  0.341
2006 Agnati LF, Ferré S, Genedani S, Leo G, Guidolin D, Filaferro M, Carriba P, Casadó V, Lluis C, Franco R, Woods AS, Fuxe K. Allosteric modulation of dopamine D2 receptors by homocysteine. Journal of Proteome Research. 5: 3077-83. PMID 17081059 DOI: 10.1021/pr0601382  0.345
2006 Franco R, Casadó V, Mallol J, Ferrada C, Ferré S, Fuxe K, Cortés A, Ciruela F, Lluis C, Canela EI. The two-state dimer receptor model: a general model for receptor dimers. Molecular Pharmacology. 69: 1905-12. PMID 16501032 DOI: 10.1124/Mol.105.020685  0.33
2006 Ciruela F, Casadó V, Rodrigues RJ, Luján R, Burgueño J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortés A, Canela EI, López-Giménez JF, Milligan G, Lluis C, ... ... Franco R, et al. Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2080-7. PMID 16481441 DOI: 10.1523/Jneurosci.3574-05.2006  0.339
2005 Saura J, Angulo E, Ejarque A, Casadó V, Tusell JM, Moratalla R, Chen JF, Schwarzschild MA, Lluis C, Franco R, Serratosa J. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. Journal of Neurochemistry. 95: 919-29. PMID 16092928 DOI: 10.1111/J.1471-4159.2005.03395.X  0.317
2005 Agnati LF, Ferre S, Burioni R, Woods A, Genedani S, Franco R, Fuxe K. Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases. Neuromolecular Medicine. 7: 61-78. PMID 16052039 DOI: 10.1385/Nmm:7:1-2:061  0.334
2005 Ciruela F, Canela L, Burgueño J, Soriguera A, Cabello N, Canela EI, Casadó V, Cortés A, Mallol J, Woods AS, Ferré S, Lluis C, Franco R. Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins: focus on adenosine, dopamine, and metabotropic glutamate receptor function. Journal of Molecular Neuroscience : Mn. 26: 277-92. PMID 16012201 DOI: 10.1385/Jmn:26:2-3:277  0.302
2005 Franco R, Ciruela F, Casadó V, Cortes A, Canela EI, Mallol J, Agnati LF, Ferré S, Fuxe K, Lluis C. Partners for adenosine A1 receptors. Journal of Molecular Neuroscience : Mn. 26: 221-32. PMID 16012195 DOI: 10.1385/Jmn:26:2-3:221  0.354
2005 Woods AS, Ciruela F, Fuxe K, Agnati LF, Lluis C, Franco R, Ferré S. Role of electrostatic interaction in receptor-receptor heteromerization. Journal of Molecular Neuroscience : Mn. 26: 125-32. PMID 16012186 DOI: 10.1385/Jmn:26:2-3:125  0.345
2005 Franco R, Casadó V, Mallol J, Ferré S, Fuxe K, Cortés A, Ciruela F, Lluis C, Canela EI. Dimer-based model for heptaspanning membrane receptors. Trends in Biochemical Sciences. 30: 360-6. PMID 15951182 DOI: 10.1016/J.Tibs.2005.05.010  0.301
2005 Torvinen M, Torri C, Tombesi A, Marcellino D, Watson S, Lluis C, Franco R, Fuxe K, Agnati LF. Trafficking of adenosine A2A and dopamine D2 receptors. Journal of Molecular Neuroscience : Mn. 25: 191-200. PMID 15784967 DOI: 10.1385/JMN:25:2:191  0.303
2005 Torvinen M, Marcellino D, Canals M, Agnati LF, Lluis C, Franco R, Fuxe K. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes. Molecular Pharmacology. 67: 400-7. PMID 15539641 DOI: 10.1124/mol.104.003376  0.34
2004 Quarta D, Borycz J, Solinas M, Patkar K, Hockemeyer J, Ciruela F, Lluis C, Franco R, Woods AS, Goldberg SR, Ferré S. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation. Journal of Neurochemistry. 91: 873-80. PMID 15525341 DOI: 10.1111/J.1471-4159.2004.02761.X  0.307
2004 Burgueño J, Canela EI, Mallol J, Lluis C, Franco R, Ciruela F. Mutual regulation between metabotropic glutamate type 1alpha receptor and caveolin proteins: from traffick to constitutive activity. Experimental Cell Research. 300: 23-34. PMID 15383311 DOI: 10.1016/J.Yexcr.2004.06.013  0.335
2004 Agnati LF, Ferré S, Leo G, Lluis C, Canela EI, Franco R, Fuxe K. On the molecular basis of the receptor mosaic hypothesis of the engram. Cellular and Molecular Neurobiology. 24: 501-16. PMID 15233375  0.301
2004 Ferré S, Ciruela F, Canals M, Marcellino D, Burgueno J, Casadó V, Hillion J, Torvinen M, Fanelli F, Benedetti Pd Pd, Goldberg SR, Bouvier M, Fuxe K, Agnati LF, Lluis C, ... Franco R, et al. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism & Related Disorders. 10: 265-71. PMID 15196504 DOI: 10.1016/J.Parkreldis.2004.02.014  0.37
2004 Canals M, Burgueño J, Marcellino D, Cabello N, Canela EI, Mallol J, Agnati L, Ferré S, Bouvier M, Fuxe K, Ciruela F, Lluis C, Franco R. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. Journal of Neurochemistry. 88: 726-34. PMID 14720222 DOI: 10.1046/J.1471-4159.2003.02200.X  0.327
2003 Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, Woods AS, Ferré S, Lluis C, Bouvier M, Franco R. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. The Journal of Biological Chemistry. 278: 46741-9. PMID 12933819 DOI: 10.1074/Jbc.M306451200  0.332
2003 Burgueño J, Enrich C, Canela EI, Mallol J, Lluis C, Franco R, Ciruela F. Metabotropic glutamate type 1α receptor localizes in low-density caveolin-rich plasma membrane fractions Journal of Neurochemistry. 86: 785-791. PMID 12887677 DOI: 10.1046/J.1471-4159.2003.01842.X  0.304
2003 Agnati LF, Ferré S, Lluis C, Franco R, Fuxe K. Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacological Reviews. 55: 509-50. PMID 12869660 DOI: 10.1124/pr.55.3.2  0.366
2003 Burgueño J, Blake DJ, Benson MA, Tinsley CL, Esapa CT, Canela EI, Penela P, Mallol J, Mayor F, Lluis C, Franco R, Ciruela F. The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. The Journal of Biological Chemistry. 278: 37545-52. PMID 12837758 DOI: 10.1074/Jbc.M302809200  0.326
2003 Franco R, Canals M, Marcellino D, Ferré S, Agnati L, Mallol J, Casadó V, Ciruela F, Fuxe K, Lluis C, Canela EI. Regulation of heptaspanning-membrane-receptor function by dimerization and clustering. Trends in Biochemical Sciences. 28: 238-43. PMID 12765835 DOI: 10.1016/S0968-0004(03)00065-3  0.328
2003 Escriche M, Burgueño J, Ciruela F, Canela EI, Mallol J, Enrich C, Lluís C, Franco R. Ligand-induced caveolae-mediated internalization of A1 adenosine receptors: Morphological evidence of endosomal sorting and receptor recycling Experimental Cell Research. 285: 72-90. PMID 12681288 DOI: 10.1016/S0014-4827(02)00090-3  0.346
2002 Ferré S, Karcz-Kubicha M, Hope BT, Popoli P, Burgueño J, Gutiérrez MA, Casadó V, Fuxe K, Goldberg SR, Lluis C, Franco R, Ciruela F. Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proceedings of the National Academy of Sciences of the United States of America. 99: 11940-5. PMID 12189203 DOI: 10.1073/Pnas.172393799  0.323
2002 Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J, Canela EI, Zoli M, Agnati LF, Ibanez CF, Lluis C, ... Franco R, et al. Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors. The Journal of Biological Chemistry. 277: 18091-7. PMID 11872740 DOI: 10.1074/jbc.M107731200  0.34
Show low-probability matches.